ImmuCell Corporation Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
ImmuCell Corporation (ICCC) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $315.73 thousand for the 3-month period ending 2018-09-30, per its 10-Q filed 2018-11-13.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2018-11-13
- ImmuCell Corporation valuation allowance, deferred tax asset, increase (decrease), amount for the quarter ending 2018-09-30 was $315.73K.
- ImmuCell Corporation valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2017 was $71.00K.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 3 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|---|
| 2018-09-30 | $315.73K 10-Q · filed 2018-11-13 | |
| 2017-12-31 | $71.00K 10-K · filed 2018-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |